ARTICLE | Clinical News
BRACAone genetic analysis for mutation linked to high risk of breast cancer
August 19, 1996 7:00 AM UTC
Myriad Genetics Inc. (MYGN), Salt Lake City, Utah Product: BRACAone genetic analysis for mutation linked to high risk of breast cancer Indication: Predict risk of breast and ovarian cancer in families...